Glaukos Corp Files 8-K with Financials

Ticker: GKOS · Form: 8-K · Filed: Nov 15, 2024 · CIK: 1192448

Sentiment: neutral

Topics: corporate-filing, financials, regulation-fd

Related Tickers: GKOS

TL;DR

Glaukos (GKOS) filed an 8-K on Nov 15, 2024, updating corporate info & financials.

AI Summary

Glaukos Corporation filed an 8-K on November 15, 2024, reporting under Regulation FD and including financial statements and exhibits. The filing details the company's principal executive offices located at One Glaukos Way, Aliso Viejo, California, 92656, and its telephone number (949) 367-9600. Glaukos Corporation is incorporated in Delaware and operates in the Surgical & Medical Instruments & Apparatus industry.

Why It Matters

This 8-K filing provides updated corporate information and financial reporting for Glaukos Corporation, which is crucial for investors and stakeholders to stay informed about the company's status and regulatory compliance.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain any significant new risks or material adverse information.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Glaukos Corporation?

The primary purpose of this 8-K filing is to report under Regulation FD and to include financial statements and exhibits as of November 15, 2024.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on November 15, 2024.

Where are Glaukos Corporation's principal executive offices located?

Glaukos Corporation's principal executive offices are located at One Glaukos Way, Aliso Viejo, California, 92656.

What is the telephone number for Glaukos Corporation?

The telephone number for Glaukos Corporation, including area code, is (949) 367-9600.

In which state is Glaukos Corporation incorporated?

Glaukos Corporation is incorporated in Delaware.

Filing Stats: 504 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-11-15 07:00:13

Filing Documents

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. Glaukos Corporation (the "Company") intends to present the materials attached as Exhibit 99.1 to this Current Report on Form 8-K (the "Investor Presentation") from time to time in presentations to investors and other stakeholders. The Investor Presentation will also be available on the investor page of the Company's website at http://investors.glaukos.com. The information contained in this Item 7.01 and in the accompanying Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits . Exhibit No. Description 99.1 Investor Presentation, dated November 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GLAUKOS CORPORATION (Registrant) By: /s/ Alex R. Thurman Name: Alex R. Thurman Title: Senior Vice President & Chief Financial Officer Date: November 15, 2024

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing